An interview with Richard M. Eglen, Ph.D.

Suppr

超能文献

作者信息

Eglen Richard M

出版信息

Assay Drug Dev Technol. 2006 Oct;4(5):503-9. doi: 10.1089/adt.2006.4.503.

DOI:10.1089/adt.2006.4.503

PMID:17115921

Abstract

摘要

相似文献

An interview with Richard M. Eglen, Ph.D.

Assay Drug Dev Technol. 2006 Oct;4(5):503-9. doi: 10.1089/adt.2006.4.503.

High throughput screening: early successes indicate a promising future.

J Biomol Screen. 2001 Jun;6(3):137-40. doi: 10.1177/108705710100600303.

An interview with Ken Valenzano, Ph.D. Interview by Vicki Glaser.

Assay Drug Dev Technol. 2011 Jun;9(3):191-7. doi: 10.1089/adt.2011.0903.pr.

Chemical genomics versus orthodox drug development.

Drug Discov Today. 2003 Feb 15;8(4):157-9. doi: 10.1016/s1359-6446(03)02599-6.

Testing time for stem cells.

Nature. 2010 Feb 11;463(7282):719. doi: 10.1038/463719a.

The role of medicinal chemists in drug discovery.

Curr Opin Drug Discov Devel. 2005 Jul;8(4):419-20.

Interview with Steven A. Haney, PhD.

Assay Drug Dev Technol. 2014 Jan-Feb;12(1):12-5. doi: 10.1089/adt.2014.1201.pr.

An interview with Kenneth C. Lewis, Ph.D., CEO, and Joseph D. Simpkins, Vice President, Software, OpAns (Optimized Analytical Solutions), Durham, NC. Interview by Vicki Glaser.

Assay Drug Dev Technol. 2007 Dec;5(6):695-702. doi: 10.1089/adt.2007.9984.

High-throughput drug discovery: what can we expect from HTS?

Drug Discov Today. 2005 Jan 1;10(1):17-22. doi: 10.1016/S1359-6446(04)03275-1.

An interview with Andrew D. Napper, Ph.D. Interview.

Assay Drug Dev Technol. 2008 Oct;6(5):611-20. doi: 10.1089/adt.2008.9985.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

An interview with Richard M. Eglen, Ph.D.

Assay Drug Dev Technol. 2006 Oct;4(5):503-9. doi: 10.1089/adt.2006.4.503.

High throughput screening: early successes indicate a promising future.

J Biomol Screen. 2001 Jun;6(3):137-40. doi: 10.1177/108705710100600303.

An interview with Ken Valenzano, Ph.D. Interview by Vicki Glaser.

Assay Drug Dev Technol. 2011 Jun;9(3):191-7. doi: 10.1089/adt.2011.0903.pr.

Chemical genomics versus orthodox drug development.

Drug Discov Today. 2003 Feb 15;8(4):157-9. doi: 10.1016/s1359-6446(03)02599-6.

Testing time for stem cells.

Nature. 2010 Feb 11;463(7282):719. doi: 10.1038/463719a.

The role of medicinal chemists in drug discovery.

Curr Opin Drug Discov Devel. 2005 Jul;8(4):419-20.

Interview with Steven A. Haney, PhD.

Assay Drug Dev Technol. 2014 Jan-Feb;12(1):12-5. doi: 10.1089/adt.2014.1201.pr.

An interview with Kenneth C. Lewis, Ph.D., CEO, and Joseph D. Simpkins, Vice President, Software, OpAns (Optimized Analytical Solutions), Durham, NC. Interview by Vicki Glaser.

Assay Drug Dev Technol. 2007 Dec;5(6):695-702. doi: 10.1089/adt.2007.9984.

High-throughput drug discovery: what can we expect from HTS?

Drug Discov Today. 2005 Jan 1;10(1):17-22. doi: 10.1016/S1359-6446(04)03275-1.

An interview with Andrew D. Napper, Ph.D. Interview.

Assay Drug Dev Technol. 2008 Oct;6(5):611-20. doi: 10.1089/adt.2008.9985.